Sorensen Tina K, Grauslund Morten, Jensen Peter B, Sehested Maxwell, Jensen Lars H
Department of Pathology, Diagnostic Centre RH5444, Copenhagen University Hospital, Frederik V's Vej 11, DK-2100 Copenhagen, Denmark.
Biochem Biophys Res Commun. 2005 Sep 2;334(3):853-60. doi: 10.1016/j.bbrc.2005.06.177.
Bisdioxopiperazines are inhibitors of topoisomerase II trapping this protein as a closed clamp on DNA with concomitant inhibition of its ATPase activity. Here, we analyse the effects of N-terminal mutations identified in bisdioxopiperazine-resistant cells on ATP hydrolysis by this enzyme. We present data consistent with bisdioxopiperazine resistance arising by two different mechanisms; one involving reduced stability of the N-terminal clamp (the N-gate) and one involving reduced affinity for bisdioxopiperazines. Vanadate is a general inhibitor of type P ATPases and has recently been demonstrated to lock topoisomerase II as a salt-stable closed clamp on DNA analogous to the bisdioxopiperazines. We show that a R162K mutation in human topoisomerase II alpha renders this enzyme highly resistant towards vanadate while having little effect on bisdioxopiperazine sensitivity. The implications of these findings for the mechanism of action of bisdioxopiperazines versus vanadate with topoisomerase II are discussed.
双二氧哌嗪是拓扑异构酶II的抑制剂,可将该蛋白捕获为DNA上的闭合夹子,并同时抑制其ATP酶活性。在此,我们分析了在双二氧哌嗪抗性细胞中鉴定出的N端突变对该酶ATP水解的影响。我们提供的数据表明,双二氧哌嗪抗性的产生有两种不同机制;一种涉及N端夹子(N门)稳定性降低,另一种涉及对双二氧哌嗪的亲和力降低。钒酸盐是P型ATP酶的通用抑制剂,最近已被证明可将拓扑异构酶II锁定为DNA上类似双二氧哌嗪的盐稳定闭合夹子。我们表明,人拓扑异构酶IIα中的R162K突变使该酶对钒酸盐具有高度抗性,而对双二氧哌嗪敏感性影响很小。讨论了这些发现对双二氧哌嗪与钒酸盐作用于拓扑异构酶II机制的影响。